| Literature DB >> 23727164 |
Giuseppe Remuzzi1, Ariela Benigni, Fredric O Finkelstein, Jean-Pierre Grunfeld, Dominique Joly, Ivor Katz, Zhi-Hong Liu, Toshio Miyata, Norberto Perico, Bernardo Rodriguez-Iturbe, Luca Antiga, Franz Schaefer, Arrigo Schieppati, Robert W Schrier, Marcello Tonelli.
Abstract
Although in some parts of the world acute and chronic kidney diseases are preventable or treatable disorders, in many other regions these diseases are left without any care. The nephrology community needs to commit itself to reduction of this divide between high-income and low-income regions. Moreover, new and exciting developments in fields such as pharmacology, genetic, or bioengineering, can give a boost, in the next decade, to a new era of diagnosis and treatment of kidney diseases, which should be made available to more patients.Entities:
Mesh:
Year: 2013 PMID: 23727164 DOI: 10.1016/S0140-6736(13)60438-9
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321